Add time:08/26/2019         Source:sciencedirect.com

Repaglinide is a nonsulfonylurea, oral hypoglycemic agent used in the treatment of type 2 diabetes mellitus. It stimulates insulin secretion by binding to the sulfonylurea receptor (SUR1) subunit of the KATP channel, thus blocking the channel, resulting in depolarization of the beta-cell membrane, and a consequent influx of Ca2 +. It is fast acting, with a short duration of action and is administered before each meal.

We also recommend Trading Suppliers and Manufacturers of Repaglinide (cas 108157-52-4). Pls Click Website Link as below: cas 108157-52-4 suppliers